These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4427225)

  • 1. Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.
    Hinderling PH; Bres J; Garrett ER
    J Pharm Sci; 1974 Nov; 63(11):1684-90. PubMed ID: 4427225
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of pKb on lipophilic binding of disopyramide derivatives to human plasma.
    Chien YW; Akers MJ; Yonan PK
    J Pharm Sci; 1975 Oct; 64(10):1632-5. PubMed ID: 241827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration.
    David BM; Tjokrosetio R; Ilett KF
    Ther Drug Monit; 1983; 5(1):81-6. PubMed ID: 6845403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of unbound fraction of disopyramide in plasma: a comparison of equilibrium dialysis, ultrafiltration through dialysis membranes and ultrafree anticonvulsant drug filters.
    Norris RL; Ahokas JT; Ravenscroft PJ
    J Pharmacol Methods; 1982 Jan; 7(1):7-14. PubMed ID: 7070107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting the binding of disopyramide to serum proteins.
    Shaw LM; Altman R; Thompson BC; Fields L
    Clin Chem; 1985 Apr; 31(4):616-9. PubMed ID: 3884182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear relationships between plasma binding and lipophilicity of disopyramide derivatives.
    Chien YW; Lambert HJ; Lin TK
    J Pharm Sci; 1975 Jun; 64(6):961-6. PubMed ID: 1133751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins.
    Chien YW; Lambert HJ; Karim A
    J Pharm Sci; 1974 Dec; 63(12):1877-9. PubMed ID: 4449018
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorescence photometric determination of disopyramide and mono-N-dealkylated disopyramide in plasma after separation by thin-layer chromatography.
    Gupta RN; Eng F; Lewis D; Kumana C
    Anal Chem; 1979 Mar; 51(3):455-8. PubMed ID: 532975
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay.
    Raghow G; Meyer MC; Straughn AB
    Ther Drug Monit; 1985; 7(4):466-71. PubMed ID: 3909539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of concentration-dependent plasma protein binding in disopyramide disposition.
    Meffin PJ; Robert EW; Winkle RA; Harapat S; Peters FA; Harrison DC
    J Pharmacokinet Biopharm; 1979 Feb; 7(1):29-46. PubMed ID: 458555
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma binding of disopyramide and mono-N-dealkyldisopyramide.
    Bredesen JE; Pike E; Lunde PK
    Br J Clin Pharmacol; 1982 Nov; 14(5):673-6. PubMed ID: 7138747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma binding of disopyramide.
    David BM; Madsen BW; Ilett KF
    Br J Clin Pharmacol; 1980 Jun; 9(6):614-8. PubMed ID: 7387819
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of blood collection technique on serum and plasma protein binding of disopyramide.
    Haughey DB; Lima JJ
    Eur J Clin Pharmacol; 1982; 22(2):185-9. PubMed ID: 7094989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of disopyramide and its mono-N-dealkylated metabolite in blood serum and urine.
    Hutsell TC; Stachelski SJ
    J Chromatogr; 1975 Mar; 106(1):151-8. PubMed ID: 1150784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle.
    Grant AM; Marshall RJ; Ankier SI
    Eur J Pharmacol; 1978 Jun; 49(4):389-94. PubMed ID: 668810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-glucosyl isothiocyanate, an affinity label for the glucose transport proteins of the human erythrocyte membrane.
    Taverna RD; Langdon RG
    Biochem Biophys Res Commun; 1973 Sep; 54(2):593-9. PubMed ID: 4756788
    [No Abstract]   [Full Text] [Related]  

  • 17. Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol.
    Garrett ER; Hunt CA
    J Pharm Sci; 1974 Jul; 63(7):1056-64. PubMed ID: 4853640
    [No Abstract]   [Full Text] [Related]  

  • 18. Gas-chromatographic determination of disopyramide and its mono-N-dealkylated metabolite in serum with use of a nitrogen-selective detector.
    Bredesen JE
    Clin Chem; 1980 Apr; 26(5):638-40. PubMed ID: 7261311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombination of human red cell membrane protein fractions with homologous lipids.
    Barzilay M; Condrea E; Ben-David E; De Vries A
    Biochim Biophys Acta; 1973 Jul; 311(4):576-93. PubMed ID: 4729831
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensitive high-pressure liquid chromatographic determination of disopyramide and mono-N-dealkyldisopyramide.
    Nygard G; Shelver WH; Khalil SK
    J Pharm Sci; 1979 Oct; 68(10):1318-20. PubMed ID: 512870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.